Analysis
Sections
Features
Comment
Projects
Most Read
Next-gen gene editing: Graphite Bio launches with $45m funding
Covid-19 pandemic may widen inequality between poor and rich countries – leading macroeconomic influencers
Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
Most Recent
deal
Next-gen gene editing: Graphite Bio launches with $45m funding
30 Sep 2020
Investment
Most Read
The relationship between FDI and international trade
What is FDI?
Why BEPS is a taxing matter for MNCs
Featured
TCR2 receives $125m funding boost for T-cell programmes
22 Mar 2018
Sectors
Sections
Clinical Trials
Supply Chain
Drug Development
Manufacturing
Diseases
Cardiovascular
Central Nervous System
Immunology
Infectious Diseases
Oncology
Respiratory
Most Read
New Two-Year Data for Evrysdi Will Lead to Increased Competition in SMA Market
Bausch Health’s intent to acquire Allegro’s ophthalmology assets offers potential opportunity to tap into lucrative indication-specific markets
How digital transformation can bring clinical trials into the 21st century
Featured
Regulation
Janssen gets FDA approval for Invokana to reduce risk of CV events
31 Oct 2018
Deals
Most Read
Next-gen gene editing: Graphite Bio launches with $45m funding
Treating lysosomal storage disorders: Gain and Sumitomo Dainippon enter partnership
Advancing next-gen CD47 antibodies: AbbVie and I-Mab sign $1.94bn partnership
Featured
Clinical Trials
Blood and urine tests detect autism in children
21 Feb 2018
Tech
Most Read
Five must-read stories from the intersection of tech, business and politics
‘Europe’s Digital Decade’: how the EU is pitching tech as the driving force behind its recovery
Five must-read stories from the intersection of tech, business and politics
Featured
Cold Chain
150f drug compounding facilities have violated FDA regulations
23 Jul 2018
Companies
Sections
Company A-Z
Product & Services
Company Releases
White Papers
Videos
Most Read
Alconox
Enamine
Nymi™
Featured
Drug Development
Cremer
26 Mar 2020
Menu
News
Analysis
Features
Comment
Projects
Investment
Sectors
Clinical Trials
Supply Chain
Drug Development
Manufacturing
Diseases
Cardiovascular
Central Nervous System
Immunology
Infectious Diseases
Oncology
Deals
Tech
Disruption
Coronavirus
Partners
Accelerating Clinical Trials
Powder Handling
Tools
Companies
Company A-Z
Product & Services
Company Releases
White Papers
Videos
Reports
Awards
Magazine
The Company
About Us
Contact Us
Advertise With Us
Visit GlobalData
Login
Register
Login
Register
US pharma industry sees a drop of 22.2% in deal activity in July 2019
23 August 2019
Pharma industry deals in July 2019 total $4.57bn globally
21 August 2019
China’s pharma industry sees a drop of 28.1% in deal activity in Q2 2019
16 July 2019
North America’s pharma industry sees a drop of 10.3% in deal activity in Q2 2019
16 July 2019
Europe’s pharma industry sees a rise of 1.2% in deal activity in Q2 2019
16 July 2019
Pharma industry M&A deals in Q2 2019 total $114.8bn globally
16 July 2019
Pharma industry venture financing deals in Q2 2019 total $2.72bn in US
16 July 2019
Pharma industry deals in Q2 2019 total $121.51bn globally
16 July 2019
Pharma industry private equity deals in Q2 2019 total $2.98bn globally
16 July 2019
Pharma industry venture financing deals in Q2 2019 total $3.72bn globally
16 July 2019
Load More
Latest News
Therapy Areas
SII to produce additional 100 million Covid-19 vaccine doses
30 Sep 2020
deal
Orgenesis agrees to take over Koligo Therapeutics
30 Sep 2020
Diseases
Pfizer to acquire 9.9% stake in CStone for $200m
30 Sep 2020
deal
XtalPi raises $318m to support AI-based drug discovery
29 Sep 2020
Company A-Z
View All
Company Releases
View All
White Papers
View All
Videos
View All
